Trial intelligence / Profile preview

Oestrogen Administration in COVID-19

NCT04853069Phase 2Unknown

Sponsor
Hamad Medical Corporation
Start
May 2021
Primary completion
Feb 2022
Countries
1
01

Overview

A Phase 2 trial of estradiol topical in coronavirus disease 2019 (COVID-19), sponsored by Hamad Medical Corporation. Status: unknown.

02

Drugs

estradiol topical
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04853069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04853069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call